Behavior of chemiluminescent assays to measure serum testosterone during androgen deprivation therapy

Int J Urol. 2016 Nov;23(11):957-958. doi: 10.1111/iju.13180. Epub 2016 Aug 3.

Authors

Juan Morote^{1

2}, Inma Comas^{3

2}, Jacques Planas^{1

2}, Ana Celma^{1

2}, Roser Ferrer^{3

2}, Lucas Regis^{4

5}

Affiliations

¹ Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain.
² Autonomous University of Barcelona, Barcelona, Spain.
³ Department of Biochemistry, Vall d'Hebron University Hospital, Barcelona, Spain.
⁴ Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. [email protected].
⁵ Autonomous University of Barcelona, Barcelona, Spain. [email protected].

PMID: 27488277
DOI: 10.1111/iju.13180

No abstract available

MeSH terms

Androgen Antagonists / therapeutic use
Antineoplastic Agents, Hormonal
Humans
Luminescent Measurements*
Male
Prostatic Neoplasms / drug therapy*
Testosterone / blood*

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal
Testosterone